October 29, 2015

Journalists love superlative terms for cancer drugs – often questionably

Posted By

Comments (4)

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Tom

October 29, 2015 at 10:44 am

Written by Dr. Prasad and a medical student? Why not give the student’s name?

Kevin Lomangino

October 29, 2015 at 10:55 am

Good point. I added it. Thanks for reading and commenting.

Kevin Lomangino
Managing Editor

Paul Alper

November 2, 2015 at 7:57 am

Prasad is the co-author of a 2015 book, “Ending Medical Reversals; Improving Outcomes, Saving Lives.” Be sure to review it because it contains a discussion of why many procedures which are plausibly put forward as beneficial, however, turn it to be useless or harmful .

Alia Bucciarelli

November 2, 2015 at 8:07 am

Thanks for bringing this article to my attention! We just covered using superlatives last week in the class that I teach on writing about health and medicine. I’m going to share this post with my students for additional context.

COMMENTS button We welcome comments, which users can leave at the end of any of our systematic story reviews or at the end of any of our blog posts.

But before leaving a comment, please review these notes about our policy.

You are responsible for any comments you leave on this site.

This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.

We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.

We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.

There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”

The authors of the Retraction Watch comments policy urge commenters:

“Shed light, not just heat. Facts, challenges, disagreements, corrections — those are all fine. Attacking the person, instead of the idea or the interpretation, is neither acceptable nor helpful.”

We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.

And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.

The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.